| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/14737175.2.3.363 |
| P698 | PubMed publication ID | 19810868 |
| P50 | author | Susanna Genedani | Q38548451 |
| P2093 | author name string | Rosaria Di Lorenzo | |
| P2860 | cites work | The impact of substance abuse on the course of bipolar disorder | Q29306635 |
| Bodyweight gain with atypical antipsychotics. A comparative review | Q32060406 | ||
| Comparative pharmacology of bipolar disorder and schizophrenia | Q33744368 | ||
| 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex | Q33912242 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| Atypical antipsychotics and weight gain--a systematic review | Q33951215 | ||
| Are schizophrenic and bipolar disorders related? A review of family and molecular studies | Q34052813 | ||
| Pharmacologic agents for the treatment of acute bipolar mania. | Q34052819 | ||
| Bipolar disorder therapeutics: maintenance treatment | Q34052830 | ||
| Atypical antipsychotics in bipolar and schizoaffective disorders | Q34219157 | ||
| Ziprasidone, a new atypical antipsychotic drug | Q34278844 | ||
| Emerging options in the treatment of bipolar disorders | Q34370458 | ||
| Clozapine. A novel antipsychotic agent | Q36485618 | ||
| Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile | Q40785107 | ||
| A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group | Q42626284 | ||
| Clozapine in the treatment of refractory psychotic mania | Q42627098 | ||
| Olanzapine in treatment-resistant bipolar disorder | Q42678439 | ||
| Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
| Atypical antipsychotics and cardiovascular risk in schizophrenic patients | Q43528848 | ||
| A consumer perspective concerning the diagnosis and treatment of bipolar disorder. | Q51973354 | ||
| Quetiapine for refractory mania in a child. | Q54313395 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 363-376 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety | |
| P478 | volume | 2 |
| Q36390795 | Bipolar disorder: historic perspective, current pharmacologic treatment options and a review of quetiapine | cites work | P2860 |
Search more.